NCT06561893

Brief Summary

Broccoli has the precursor of an active compound (sulforaphane) that has shown a wide range of health promoting benefits. Sulforaphane formation depends on the conversion of glucoraphanin (precursor) by myrosinase enzyme. Thus, the bioavailability of sulforaphane is affected by myrosinase activity. Some bacteria, such as L. plantarum (probiotic), have shown they can also convert glucoraphanin to sulforaphane in vitro. This study investigates the effect of short-term L. plantarum supplementation on broccoli sulforaphane bioavailability in humans using a randomised double-blind placebo-controlled crossover trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 20, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2025

Completed
Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

7 months

First QC Date

June 18, 2024

Last Update Submit

April 29, 2026

Conditions

Keywords

broccolisulforaphaneprobioticgut microbiotaL. plantarumbioavailabilitycross-over trial

Outcome Measures

Primary Outcomes (1)

  • Bioavailability of sulforaphane

    Bioavailability (%) of sulforaphane (will be estimated by dividing the cumulative amount of sulforaphane mercapturic acid excreted in urine in 24 h by the consumed amount of glucoraphanin (Vermeulen et al., 2008)) before and after chronic consumption of L. plantarum compared with placebo.

    From baseline to the end of each condition at 2 weeks, followed by 2 weeks of wash-out, and before and after the next condition

Secondary Outcomes (3)

  • Sulforaphane pharmacokinetics: Area under the curve

    From baseline to the end of each condition at 2 weeks, followed by 2 weeks of wash-out, and before and after the next condition.

  • Sulforaphane pharmacokinetics: Cmax

    From baseline to the end of each condition at 2 weeks, followed by 2 weeks of wash-out, and before and after the next condition.

  • Sulforaphane pharmacokinetics: Tmax

    From baseline to the end of each condition at 2 weeks, followed by 2 weeks of wash-out, and before and after the next condition.

Study Arms (2)

Probiotic (L. plantarum) supplementation

ACTIVE COMPARATOR

Dose: 20 Billion CFU/day for 14 days (total of two pills of 10 Billion CFU)

Dietary Supplement: Broccoli sprouts extract supplementation

Placebo (dextrose) supplementation

PLACEBO COMPARATOR

Dose: 700 mg of dextrose (total of two pills; 2 x 350 mg pills)

Dietary Supplement: Broccoli sprouts extract supplementation

Interventions

Intake of broccoli sprouts extract supplement (Brand: Source Naturals, Scotts Valley, CA 95066 - USA) in an acute dose (84 umol of glucoraphanin) before and after 2 weeks of probiotic or placebo supplementation, to assess sulforaphane bioavailability measured in urine metabolites

Placebo (dextrose) supplementationProbiotic (L. plantarum) supplementation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy adults (male and female)
  • age range of 18-65 years
  • BMI range of 18-30 kg/m2

You may not qualify if:

  • have been on a course of antibiotics within the period of the past 3 months.
  • have allergies or intolerance towards probiotic substances or broccoli used in the study and/or food intolerances associated with gastrointestinal upset.
  • have been taking pre- or probiotics supplements regularly during the last month prior (this does not include foods containing probiotics and/or prebiotics foods)
  • are following any restricting diet (e.g., vegan, FODMAP, etc.).
  • have a gastrointestinal inflammatory condition (e.g., irritable bowel syndrome, inflammatory bowel diseases, coeliac diseases, constipation, etc.).
  • have a medical condition or take medication for any heart, endocrine, or metabolic condition, such as high blood pressure, high cholesterol, insulin resistance, or diabetes, or autoimmune disease.
  • are a pregnant and/or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Department of Public Health and Sport Sciences, University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter

Exeter, Devon, EX1 2 LU, United Kingdom

Location

Richard's Building, St Luke's Campus

Exeter, Devon, EX2 4TA, United Kingdom

Location

Related Publications (7)

  • Oloyede OO, Wagstaff C, Methven L. The Impact of Domestic Cooking Methods on Myrosinase Stability, Glucosinolates and Their Hydrolysis Products in Different Cabbage (Brassica oleracea) Accessions. Foods. 2021 Nov 24;10(12):2908. doi: 10.3390/foods10122908.

    PMID: 34945460BACKGROUND
  • Gonzalez F, Quintero J, Del Rio R, Mahn A. Optimization of an Extraction Process to Obtain a Food-Grade Sulforaphane-Rich Extract from Broccoli (Brassica oleracea var. italica). Molecules. 2021 Jul 1;26(13):4042. doi: 10.3390/molecules26134042.

    PMID: 34279379BACKGROUND
  • Iahtisham-Ul-Haq, Khan S, Awan KA, Iqbal MJ. Sulforaphane as a potential remedy against cancer: Comprehensive mechanistic review. J Food Biochem. 2022 Mar;46(3):e13886. doi: 10.1111/jfbc.13886. Epub 2021 Aug 5.

    PMID: 34350614BACKGROUND
  • Surono IS, Simatupang A, Kusumo PD, Waspodo P, Verbruggen S, Verhoeven J, Venema K. Effect of Different Functional Food Supplements on the Gut Microbiota of Prediabetic Indonesian Individuals during Weight Loss. Nutrients. 2022 Feb 13;14(4):781. doi: 10.3390/nu14040781.

    PMID: 35215431BACKGROUND
  • Ye JH, Huang LY, Terefe NS, Augustin MA. Fermentation-based biotransformation of glucosinolates, phenolics and sugars in retorted broccoli puree by lactic acid bacteria. Food Chem. 2019 Jul 15;286:616-623. doi: 10.1016/j.foodchem.2019.02.030. Epub 2019 Feb 14.

    PMID: 30827654BACKGROUND
  • Cai YX , Augustin MA , Jegasothy H , Wang JH , Terefe NS . Mild heat combined with lactic acid fermentation: a novel approach for enhancing sulforaphane yield in broccoli puree. Food Funct. 2020 Jan 29;11(1):779-786. doi: 10.1039/c9fo02089f.

    PMID: 31922158BACKGROUND
  • Vermeulen M, Klopping-Ketelaars IW, van den Berg R, Vaes WH. Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J Agric Food Chem. 2008 Nov 26;56(22):10505-9. doi: 10.1021/jf801989e.

    PMID: 18950181BACKGROUND

Study Officials

  • Luciana Torquati, PhD

    University of Exeter

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomised Double-blind Placebo-controlled Crossover Study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2024

First Posted

August 20, 2024

Study Start

October 1, 2024

Primary Completion

April 15, 2025

Study Completion

April 15, 2025

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Participant details (name, age, sex, etc.) will be stored in a password secured as per university guidelines. Participants will be allocated a code (ID number) at enrolment, and this will be used to refer to them hereafter. Data will be collected and entered under a participant's ID number, and analysed and stored as such. Only researchers listed in this application will have access to all data. Presentations, reports and publications will only include aggregated data with no personal or individual data included. Anonymised databases will be made available upon request or deposit in open repository upon request of journal.

Locations